GAMA
ARRY

Graticule Asia Macro Advisors’s Array Biopharma Inc ARRY Stock Holding History

Graticule Asia Macro Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-360,300
Closed -$3.22M – 169
2017
Q1 		$3.22M Sell
360,300
-4,700
-1% -$50K 0.19% 85
2016
Q4 		$3.21M Buy
+365,000
New +$2.69M 0.39% 63

Other funds holding ARRY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Graticule Asia Macro Advisors's ARRY Position: Q2 2017 in Review

Graticule Asia Macro Advisors sold out of Array Biopharma Inc (ARRY) in Q2 2017, closing a stake of 360,300 shares — an estimated $3.22M sold.

Graticule Asia Macro Advisors first reported a position in ARRY in Q4 2016 and held it in 2 quarters. The position peaked at $3.22M in Q1 2017. 182 funds tracked by Wall St. Rank hold ARRY as of Q2 2017.

  • Graticule Asia Macro Advisors reported no remaining Array Biopharma Inc position as of Q2 2017 after selling out during the quarter.
  • Graticule Asia Macro Advisors sold 360,300 Array Biopharma Inc shares in Q2 2017, an estimated $3.22M.
  • Graticule Asia Macro Advisors first reported a position in Array Biopharma Inc in Q4 2016 and held it in 2 quarters.
  • Graticule Asia Macro Advisors's Array Biopharma Inc position peaked at $3.22M in Q1 2017.
  • 182 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2017.

Based on Graticule Asia Macro Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.